PCIA
BIIB icon

Prime Capital Investment Advisors’s Biogen BIIB Stock Holding History

Prime Capital Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Sell
2,427
-603
-20% -$115K 0.01% 687
2026
Q1 		$555K Sell
3,030
-196
-6% -$36.1K 0.01% 647
2025
Q4 		$568K Sell
3,226
-525
-14% -$85.8K 0.01% 612
2025
Q3 		$525K Sell
3,751
-304
-7% -$41.1K 0.01% 617
2025
Q2 		$509K Buy
4,055
+1,419
+54% +$177K 0.01% 614
2025
Q1 		$361K Sell
2,636
-638
-19% -$91.2K ﹤0.01% 776
2024
Q4 		$501K Sell
3,274
-1,805
-36% -$304K 0.01% 568
2024
Q3 		$984K Sell
5,079
-5,201
-51% -$1.09M 0.01% 449
2024
Q2 		$2.38M Sell
10,280
-1,856
-15% -$403K 0.04% 294
2024
Q1 		$2.62M Sell
12,136
-2,063
-15% -$483K 0.04% 298
2023
Q4 		$3.67M Buy
+14,199
New +$3.49M 0.06% 237
2021
Q2 		– Sell
-93
Closed -$26K – 394
2021
Q1 		$26K Buy
+93
New +$25.1K ﹤0.01% 377
2020
Q1 		– Sell
-74
Closed -$22K – 486
2019
Q4 		$22K Hold
74
– – ﹤0.01% 394
2019
Q3 		$17K Buy
+74
New +$17.2K ﹤0.01% 439
2019
Q1 		– Sell
-67
Closed -$20K – 317
2018
Q4 		$20K Buy
+67
New +$21.4K 0.01% 212

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Prime Capital Investment Advisors's BIIB Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Biogen (BIIB) stake by 20% in Q2 2026, selling an estimated $115K and leaving 2,427 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #687.

Prime Capital Investment Advisors first reported a position in BIIB in Q4 2018 and has held it in 15 quarters since. The position peaked at $3.67M in Q4 2023. 752 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Prime Capital Investment Advisors held 2,427 shares of Biogen worth $524K as of Q2 2026.
  • Prime Capital Investment Advisors sold 603 Biogen shares in Q2 2026, an estimated $115K.
  • Biogen made up 0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #687 holding.
  • Prime Capital Investment Advisors first reported a position in Biogen in Q4 2018 and has held it in 15 quarters since.
  • Prime Capital Investment Advisors's Biogen position peaked at $3.67M in Q4 2023.
  • 752 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.